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Molecular cloning is a cornerstone of biomedical, biotech-
nological, and synthetic biology research. As such, improved
cloning methodologies can significantly advance the speed
and cost of research projects. Whereas current popular clon-
ing approaches use in vitro assembly of DNA fragments, in vivo
cloning offers potential for greater simplification. It is generally
assumed that bacterial in vivo cloning requires Escherichia coli
strains with enhanced recombination ability; however, this
is incorrect. A widely present, bacterial RecA-independent re-
combination pathway is re-emerging as a powerful tool for
molecular cloning and DNA assembly. This poorly understood
pathway offers optimal cloning properties (i.e. seamless, direc-
tional, and sequence-independent) without requiring in vitro
DNA assembly or specialized bacteria, therefore vastly simplify-
ing cloning procedures. Although the use of this pathway to per-
form DNA assembly was first reported over 25 years ago, it failed
to gain popularity, possibly due to both technical and circum-
stantial reasons. Technical limitations have now been over-
come, and recent reports have demonstrated its versatility for
DNA manipulation. Here, we summarize the historical trajec-
tory of this approach and collate recent reports to provide a
roadmap for its optimal use. Given the simplified protocols and
minimal requirements, cloning using in vivo DNA assembly in
E. coli has the potential to become widely employed across the
molecular biology community.
DNA manipulation has revolutionized biomedical research
and synthetic biology. The ability to design, modify, and assem-
ble DNA pieces with almost limitless creativity has allowed
unprecedented investigation of molecular and cellular physiol-
ogy as well as the creation of synthetic life (1, 2). Restriction
enzymes were historically groundbreaking for this aim (3), but
carry some limitations. These enzymes rely on the presence (or
absence) of specific recognition sequences for their action, and
so inevitably leave sequence “scars” in the final DNA products.
Coupled with the laborious protocols involved, the constraints
of this approach have driven the development of novel cloning
techniques offering greater flexibility and simplicity. Currently,
the most popular approaches are “homology-based” cloning
methods. These techniques use small homologous sequences at
the termini of DNA fragments, normally introduced using PCR,
to drive the assembly of desired circular products. The majority
of homology-based approaches perform DNA fragment assem-
bly in a sequence-independent, directional, and seamless (scar-
free) manner, offering complete flexibility on DNA construct
design. A plethora of different homology-based methodologies
have been developed, employing a diverse range of mechanisms
for DNA assembly (e.g. LIC (ligation-independent cloning) (4),
Gibson assembly (5), In-fusion cloning (6), SLIC (7), SLiCE (8,
9), yeast gap-repair cloning (10 –12), RecET,  phage (7, 13),
and USER (14) among others). Current state-of-the-art meth-
ods predominantly involve in vitro assembly of DNA fragments,
such as by enzymatic action or ssDNA3 annealing, prior to
transformation into Escherichia coli for plasmid propagation.
DNA assembly can also be performed in vivo, circumventing
the requirement for in vitro treatments. Bacterial in vivo recom-
bination (or recombineering) offers greater simplicity than in
vitro assembly approaches. These techniques involve transfor-
mation of exogenous DNA fragments into E. coli, which are
ligated in vivo into desired sequences by the action of recombi-
nase enzymes. Recombinase enzymes, such as endogenous
RecA or phage-derived RecE/RecT, form new DNA sequences
by fusing fragments using homologous sequences between dif-
ferent DNA molecules (7, 13, 15). However, the ability of these
enzymes to recombine DNA also causes plasmid instability,
inducing deletions, multimerization, or genomic integration of
the plasmid sequence (16 –18). It is for this reason that “recom-
bination-deficient” bacterial strains, lacking RecA or RecE/
RecT expression (19, 20), are ubiquitously used for the growth
and maintenance of plasmid DNA across the molecular biology
community.
However, widely used laboratory E. coli strains are not in fact
recombination-deficient. An E. coli RecA-independent recom-
bination (RAIR) exists and was first exploited as a cloning tool
almost 30 years ago (21). Although never gaining popularity in
the intervening years, this pathway has recently re-emerged as a
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powerful method for simplified plasmid cloning (22–26). By
using in vivo assembly of DNA fragments, driven by short ho-
mologous sequences, this approach allows versatile cloning to
be performed using standard laboratory E. coli strains, without
the need for in vitro DNA assembly and avoiding the plasmid
instability of recombineering strains. This promising technique
offers a simple and powerful cloning approach, which is readily
accessible to any molecular biologist. Currently there is poor
awareness of the RecA-independent recombination pathway’s
existence, and confusion remains over the need for specialized
recombination cloning strains. Here, we aim to clarify this con-
fusion, offering a historical perspective of the technique’s tra-
jectory, a summary of current mechanistic understanding, and
a roadmap for optimal employment as a molecular cloning and
DNA assembly tool.
Using E. coli RecA-independent recombination for DNA
assembly
In this review, we focus on the in vivo assembly of DNA using
a recombination pathway that is endogenous to standard labo-
ratory E. coli, including those that are deficient in RecA. We
refer to this pathway as RAIR. Strains expressing alternative
recombinases such as RecE/T or Red (27) have also been used
for in vivo recombination cloning. Whereas these pathways
could also be considered “RecA-independent recombination,”
the cloning methodology that we discuss here uses common
laboratory bacterial strains and does not require enhanced
recombinase activity.
Upon transformation of linear dsDNA, the RAIR pathway
joins DNA fragments containing homologous sequences at
their termini to form a circular plasmid product that will
undergo propagation. The pathway efficiently joins short ho-
mologous sequences of around 15–30 bp, which can be conve-
niently introduced by PCR or through DNA synthesis. Using
specific primer design, as detailed in Fig. 1, all plasmid DNA
modifications can be performed. These include both simple
protocols (insertion or deletion of sequences, point mutagene-
sis (Fig. 1A), and subcloning (Fig. 1B) (22, 28–35) and more
complex procedures, such as performing multiple insertions,
deletions, or mutations, simultaneous assembly of multiple
DNA fragments (22, 25, 36), library creation (22, 32), or com-
binations of different modifications (22) (Fig. 2). Generally, all
procedures follow three steps: homology generation (predom-
inantly PCR), DNA cleanup, and transformation for DNA
assembly. The simplest option for DNA cleanup is post-PCR
incubation with the methylation-sensitive restriction enzyme
DpnI, which cuts methylated template DNA at the abundant
dam site “Gm6ATC,” but does not cut the newly amplified PCR
products (37). Multiple protocol variations are possible for
cloning using the RAIR pathway, with advantages dependent
on the specific aims of the required cloning project. These
details will be discussed below in greater depth. Overall, use of
this recombination pathway offers the benefits of the most ver-
satile homology-based cloning methods while requiring no spe-
cialized bacteria or commercial kits, thus vastly simplifying
molecular cloning procedures.
A historical perspective: Why was this technique
neglected?
The employment of RecA-independent recombination for
molecular cloning was first reported almost 3 decades ago. In
the first study, Douglas Jones and Bruce Howard (21) described
their “recombination PCR” method for plasmid mutagenesis or
subcloning. The method required PCR amplification of a tem-
plate DNA using primers to introduce homologous regions,
which directed DNA assembly by recombination upon trans-
Figure 1. Primer design for generation of homologous regions. A, insertions, deletions, and mutagenesis require vector amplification to produce a linear
product, re-circularized by a single recombination event on transformation. Primers bind astride the modification site, with homologous regions encoded at
5 primer ends. B, subcloning of insert DNA requires generation of distinct homology arms (colored) to drive directional assembly of two fragments. C, a length
of at least 15 bp (top) and increased binding strength (bottom) of homologous DNA regions enhances recombination efficiency (based on data from Ref. 22).
D, PCR Protocols textbook cover, published 1993, depicting “Recombination PCR” cloning by Jones and Howard. Reproduced with permission from Springer
Nature.
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formation into the DH5 E. coli strain. Despite its inclusion in
molecular biology textbooks on multiple occasions (38 –40),
including representation on the cover of PCR Protocols in 1993
(Fig. 1D), the technique never gained widespread popularity.
The original report (21) has received 32 citations to date since
1991, whereas a more popular recent cloning method, Gibson
assembly (5), has accumulated 1725 citations since its publica-
tion in 2009 (PubMed records until July 2019). Early improve-
ments to the initial protocol mainly focused on post-PCR
removal of template DNA, employing enzymatic digestion (33,
41), isolation of desired products by gel purification (42), or
reduction of the quantity of template DNA used (34). Further
approaches to enhance method efficiency included the use of a
nonmutagenic primer pair within the antibiotic resistance
gene, so that amplification of this essential sequence in two
halves will forcibly enhance selection of correctly recombined
clones (33, 35). Post-PCR DNA clean-up has been achieved by
generation of DpnI-expressing E. coli strains for in vivo
destruction of template DNA (30), yet this approach signifi-
cantly complicates plasmid maintenance, offering little experi-
mental advantage. Since the original study, cloning using the
RAIR pathway has been only sporadically reported, with its
main use in high-throughput applications, such as cloning of
thousands of open reading frames from human liver samples
(31) or Campilobacter jejuni (29).
It was only in recent years that this method really gained
traction, with a number of reports demonstrating the potential
of the approach to simplify all plasmid cloning protocols (22–
26, 32, 36, 43). Why has this technique failed to gain popularity
for so long? There are several reasons that are likely to have
delayed its widespread use. First, the technique relies on PCR
amplification and was first reported at a time when the fidelity
and processivity of polymerases were limited (44). Accurate
and successful amplification of a large plasmid sequence would
have been difficult, and the laborious protocols for gene
sequencing required at the time, would have made this unap-
pealing. Second, introduction of overlapping sequences by PCR
requires longer primers, which would have added substantial
synthesis costs compared with restriction enzyme–mediated
cloning. Indeed, multiple reports cited the cost of oligonucleo-
tides as the major caveat of PCR-based approaches (45–47).
Third, two recombination cloning reports, Bubeck et al. (28)
Figure 2. The capabilities and versatility of the RAIR cloning approach. Primers to perform individual modifications (insertions, deletions, mutagenesis,
and subcloning; center) can be combined to perform multiple modifications of the same type (left) or complex procedures from multiple modifications of
different types (right).
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and Oliner et al. (48), were coincidentally published. Despite
the former study using RAIR and the latter using the RecET
pathway, both reports have often been referred to indistin-
guishably. Since then, confusion has clouded the use of RAIR,
and cloning using in vivo E. coli recombination was predomi-
nantly attributed to the use of specialized strains with enhanced
recombination activity (15, 48–50). Finally, having been referred
to as “black box” cloning, the lack of mechanistic understanding
will have hindered the uptake and appreciation of this molecu-
lar cloning approach.
In the last few decades, the fidelity and processivity of DNA
polymerases have dramatically improved, and the cost of oligo-
nucleotide synthesis and DNA sequencing have become easily
affordable. Taq polymerase has been replaced by engineered
enzymes, such as Phusion and Q5, with 50-fold improved
error rate and higher processivity (51). Oligonucleotides can be
purchased cheaply for at least 110-bp sequences, allowing con-
siderable-sized sequences to be introduced using PCR primers.
With these developments in hand, use of the bacterial RecA-
independent pathway for molecular cloning can finally realize
its potential.
The recombination mechanism: Opening the black box
Despite its use as a cloning tool, the mechanism of RecA-
independent recombination is poorly characterized, with many
enzymes involved in the pathway and with the mechanisms by
which they act yet to be identified. Active research was con-
ducted 3 decades ago, but it was only recently, with develop-
ment of cloning applications, that further mechanistic studies
have been conducted. First insights into the recombination
mechanism came from observing the re-circularization of lin-
earized plasmid after transformation into E. coli (52, 53). Re-
circularization in recA strains was observed frequently, with
fusion occurring at sites with sequence similarities, suggesting
a dependence on homology. Preferential re-circularization
occurred at sites closer to linear DNA ends, an observation later
confirmed by others (54). Reported homology requirements for
the RAIR pathway are very low, suggested to be as little as 10 bp
(28), 6 bp (55), or even just 4 bp (21), yet there is a significant
increase in efficiency with longer stretches of homology (22, 23,
32) (Fig. 1C). Further mechanistic characterization using engi-
neered homology regions demonstrated that successful recom-
bination requires linear DNA ends (28), and for insertion of
a DNA fragment, recombination could not take place with-
out linearization between the vector’s homologous sequences.
Homology regions do not need to be at the termini of the frag-
ments, as recombination can occur using sequences at least 180
bpfromfragmentends(23).Insuchcases,theinterveningnonho-
mologous sequence between homologous regions and linear
DNA termini is lost from the final product (21, 28, 52). From
their work on plasmid re-circularization, Conley et al. (53) pro-
posed that RAIR occurred through a single-strand annealing
mechanism. In this model, in vivo 3 to 5 exonuclease activity
would produce ssDNA at linear ends, which can anneal through
short regions of homology to be subsequently repaired by po-
lymerases and ligases (Fig. 3) (53). Such a mechanism would
explain the preference for recombination at homology sites
close to linear termini, as those more distant are less likely to be
converted to ssDNA. It also explains the loss of nonhomo-
logous DNA termini, which would be excluded after DNA
repair. From analysis of recombination in mutant E. coli strains,
Figure 3. Current understanding of the RecA-independent recombination mechanism. Homologous regions at the termini of linear DNA fragments (1) are
converted to ssDNA by 3 to 5 action of exonuclease III (2) before homology-directed annealing (3) and repair of dsDNA through contribution of DNA
polymerase I (4). Further contributions of protein interactions, such as homology recognition, ssDNA-binding proteins, or DNA ligases, are current unclear
(question marks, red type).
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Conley et al. (52) demonstrate a dramatic reduction in plasmid
re-circularization in xth1 mutant bacteria, a gene encoding exo-
nuclease III (ExoIII). This protein was proposed to be the factor
producing single-stranded ends by action on double-stranded
linear DNA, allowing homologous sequence annealing (52).
The single-strand annealing hypothesis was supported by
a study showing that the efficiency of recombination was
increased by almost 2 orders of magnitude in bacterial strains
deficient for ssDNA exonucleases (56). Such proteins would
degrade the single-stranded homologous regions that are re-
quired for annealing to direct re-circularization.
A recent thorough analysis of RAIR cloning ability in bacte-
rial mutant strains showed that cloning is specifically impaired
in ExoIII mutants (xthA) (57), elegantly confirming the obser-
vations of Conley et al (53). The impaired recombination in
xthA strains can be circumvented by transformation of DNA
with homology arms already exposed as ssDNA (57), further
supporting the single-strand annealing hypothesis. Interest-
ingly, ExoIII has previously been employed ex vivo as a tool for
DNA assembly (58, 59) in a familiar procedure where incuba-
tion of homology containing DNA with ExoIII yields sequences
that could be annealed in vitro. The possibility of in vivo enzy-
matic action or of cloning without enzymatic treatment was not
considered or assessed by the authors.
As the single-strand annealing mechanism of RAIR uses
DNA with free termini (28), with no requirement for “repair
template” DNA, it has been proposed to act endogenously for
emergency repair of dsDNA breaks (60). This mechanism
would result in mutagenic repair, deleting the intervening
genomic sequence between homologies. The report by Nozaki
and Niki (57) shows little requirement for other exonucleases,
such as RecBCD, which had previously been implicated in this
recombination pathway (61). The lack of RecBCD dependence
of RAIR cloning is interesting, given that RecA-independent
but RecBCD-dependent repair of double-strand breaks has
been described in multiple bacterial species, such as Mycobac-
terium smegmatis (62, 63), Deinococcus radiodurans (64), and
E. coli (61, 65). In a study of microhomology-mediated plasmid
re-circularization, with a strong resemblance to RAIR, Chayot
et al. (65) implicate exonuclease activity of RecBCD in ssDNA
production and the DNA ligase LigA in final repair. Recombi-
nation cloning ability is not lost in mutants of RecB, RecC, or
RecD (57), so this likely represents a DNA repair pathway dis-
tinct from that which is required for plasmid circularization.
Exonuclease exposure of ssDNA would require gap-filling and
ligation (Fig. 3). Nozaki et al. (57) further demonstrate a sub-
stantial contribution of DNA polymerase I (polA) activity for
RAIR cloning, which had also previously been suggested as a
mechanistic player (53). It remains to be seen whether plasmid
assembly is completed by LigA when cloning using the RAIR
pathway.
It now seems clear that upon transformation, double-stranded
linear DNA molecules are the substrate for 3-5-exonuclease
action by ExoIII, which yields single-stranded homologous
DNA sequences. These sequences can anneal, and the resulting
gaps are filled, likely by DNA polymerase I, to complete plasmid
circularization (Fig. 3). Beyond this, further details of the
recombination mechanism remain unclear. Are single-
stranded binding proteins required for DNA stability? Does
single-strand annealing require homology recognition factors,
as other recombination mechanisms do (66), or does it simply
rely on annealing by conventional base-pairing? Which enzymes
are required for full repair of circular DNA? Although the
mechanism of recombination is now becoming clearer, the pic-
ture is not yet fully complete.
An unappreciated role for RAIR in other cloning
approaches
The homologous regions engineered to assemble DNA seg-
ments using in vivo assembly are virtually identical to those
employed by in vitro homology-based cloning methods such as
In-fusion (6), SLiCE (8, 9), or Gibson assembly (5). As all clon-
ing methods end with transformation into E. coli, the efficiency
of these in vitro homology-based methods is likely to be
enhanced by in vivo RAIR. A recent study showed that the
majority of DNA fragments are left unassembled using in vitro
enzymatic assembly methods (67) and therefore are substrates
for in vivo assembly. Therefore, the RAIR pathway potentially
offers unappreciated support to many homology-based meth-
ods. Indeed, qPCR comparison of in vitro assembly efficiency
between Gibson and restriction/ligation shows that similar lev-
els of successfully assembled products prior to transformation
yield a greater number of colonies for Gibson than for restric-
tion enzymes (31). As Gibson assembly produces homology-
containing linear DNA, a substrate for RAIR, whereas restric-
tion enzymes do not, it is very possible that in vivo assembly is
supporting this technique. This consideration should not be
overlooked when assessing the efficiency of homology-based
cloning methods (68), and true calculation of method efficiency
would require a RAIR-deficient strain or quantification of in
vitro assembly (67).
A number of homology-based methodologies have unclear
assembly mechanisms, which most likely rely on the RAIR
pathway. Without direct evidence for successful in vitro DNA
assembly, such as gel electrophoresis visualization of intact cir-
cular DNA prior to transformation, it is difficult to be sure that
such techniques do not predominantly rely on the RAIR path-
way. For example, two homology-based methods have been
proposed to occur by in vitro DNA annealing but appear most
likely to rely on recombination in vivo. The first, FastCloning
(43), is a homology-based cloning method requiring no in vitro
assembly step. After PCR amplification to introduce homo-
logous overlaps between DNA fragments and DpnI destruction
of template DNA, amplified products are transformed into
E. coli for propagation. However, the authors suggested that the
3-5-exonuclease activity of proofreading DNA polymerases in
the final cycles of the PCR, enhanced by depletion of nucleo-
tides in the reaction, would leave ssDNA available for annealing
in vitro. Similarly, the polymerase incomplete primer extension
(PIPE) method (69) follows the same procedure, and the
authors suggested that the incomplete action of DNA polymer-
ases during PCR would produce single-stranded termini for
annealing prior to transformation. It has now been demon-
strated that neither proofreading enzymes nor incomplete PCR
are required. The “polymerase incomplete” notion, which is the
basis of PIPE, has its roots in a historic observation that Taq
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polymerase can produce incompletely amplified DNA frag-
ments (70). PIPE, among other studies (22, 23, 25, 43), uses
newly engineered polymerases with greater processivity, which
are unlikely to leave incomplete termini. Second, both Taq
(nonproofreading) and Phusion (proofreading) enzymes are
sufficient for successful cloning using the RAIR pathway (22,
69); therefore, 3-5-exonuclease activity of polymerases in
vitro is not needed for a successful assembly. Last, DNA assem-
bly is efficient even if vector DNA is linearized directly with
restriction enzymes, which do not leave single-stranded homo-
logous termini (22, 23, 28). Therefore, these techniques likely
use in vivo assembly through the RAIR pathway.
Finally, even routine protocols that are widely employed in
molecular biology laboratories have been demonstrated
to rely on in vivo recombination. The QuikChangeTM muta-
genesis approach was originally suggested to produce a
nicked circular plasmid containing the desired mutation,
with nicks being repaired in vivo. Developments of this
approach have shown protocols to perform not just muta-
tions, but also insertions and deletions, assuming a similar
mechanism (71, 72). A “nicked plasmid” PCR would theoret-
ically amplify with linear rather than exponential DNA accu-
mulation, as it would be reliant on template DNA for ampli-
fication in all cycles. Amplification, however, has been
shown to be nonlinear, and PCR products seem to be linear
dsDNA with homologous sequences at the termini, where
the desired point mutation is introduced (73). Through
observations that enhanced efficiency and improved PCR
amplification can be achieved using offset rather than fully
overlapping primers (74), and observing that the linear DNA
fragment has, in fact, homology-containing dsDNA, it is evi-
dent that the mechanism of QuikChangeTM mutagenesis
relies on RAIR rather than nicked plasmid formation (73).
A roadmap for the use of the RAIR pathway in molecular
cloning
Recent reports reviving the use of the RAIR pathway for
molecular cloning have offered both proof-of-concept studies
highlighting the power of the approach (23, 25, 26) and devel-
opment of complete systems that allow complex cloning strat-
egies to be achieved (22, 32). We have synthesized reported
protocols to offer a method overview, with optimal procedures
for different cloning scenarios. We focus predominantly on
recent reports, because technical developments make the pro-
cedures employed in early studies of less relevance.
While all employ RAIR as a common mechanism for DNA
assembly, different routes for generation of homology-con-
taining DNA can be pursued (Fig. 4), with all protocols follow-
ing a similar scheme: (a) production of homologous sequences,
(b) removal of residual plasmid DNA, and (c) transformation
into E. coli.
Figure 4. A roadmap of protocols for application of cloning by in vivo assembly. Cloning can proceed through four routes for generation of homologous
regions. DNA cleanup is required prior to transformation in each case to remove original template circular DNA. Fragments can be amplified either using a
single-tube (1) or separate tube (2) PCR, with template DNA destroyed by DpnI incubation. Unamplifiable vectors can be linearized by restriction digestion (3)
and co-transformed with PCR-amplified insert containing homologous regions. Finally, direct co-transformation of synthesized dsDNA with target vector DNA
linearized by PCR or restriction digestion can be employed (4).
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Route 1: Single-tube PCR
The simplest method for cloning using RAIR consists of a
single-tube, single-step PCR where all primers and vectors are
added to a single reaction. After amplification and DpnI incu-
bation, all fragments will be directly co-transformed into com-
petent E. coli for assembly (22). This approach can be used for
the majority of cloning procedures. Although unconventional,
multiple vectors can be reliably amplified simultaneously,
greatly simplifying complex procedures (Fig. 2) (22). Designing
homologous regions with a melting temperature (Tm) lower
than that of template-binding regions will prevent potential
primer-dimer–induced issues. However, if homologous regions
are extended (e.g. for enhanced efficiency during complex assem-
blies), there is a possibility that homologous regions could bind
together, hindering PCR amplification. Troubleshooting such
issues can be achieved by confirmation of separate fragment
amplification using independent PCRs (i.e. Route 2).
Route 2: Multi-tube PCR
Individual fragments are amplified in separate reactions and
mixed prior to transformation (23, 25, 32). This approach is
particularly useful either when the use of multiple primers
limits DNA amplification or when nonspecific amplification
occurs and DNA fragments would require purification. Ampli-
fication products are similarly treated with DpnI and co-trans-
formed into bacteria.
Route 3: Vector digestion
Some vector backbones cannot be amplified by PCR due to
high GC content or repeat sequences (e.g. particular expression
vectors (75) or viral backbone plasmids (22)). In such cases,
vectors can be linearized by restriction digestion before
co-transformation with PCR-amplified inserts containing re-
gions homologous to the termini of linearized vector DNA (22,
23, 28, 32). Although more laborious than vector amplification
(Routes 1 and 2), this approach allows cloning when PCR of
vector DNA cannot be conducted.
Route 4: Gene synthesis insertion
Synthesis of custom linear dsDNA fragments is now com-
mercially available (e.g. gBlocks). This offers a simple and ver-
satile alternative for the generation of novel custom sequences
that can be directly transformed into bacteria if they contain
appropriate homologous regions to recombine with a linear-
ized vector, as has been demonstrated for PCR-based gene syn-
thesis (76). This is a particularly versatile approach to assemble
several custom DNA fragments, which is of high value to syn-
thetic biology. Although currently more expensive that PCR-
based approaches, this route may see greater adoption as DNA
synthesis services become increasingly affordable or where
PCR amplification of insert sequences is not possible.
Optimization of cloning efficiency using the RAIR
pathway
The RAIR pathway is very efficient for DNA assembly. Up to
6 fragments have been assembled in vivo using the RAIR path-
way (25, 32), but as with any other method, the efficiency of
cloning decreases with increasing complexity, resulting in
fewer colonies (22). The decrease in efficiency likely results
from the need to co-transform and successfully recombine sev-
eral DNA fragments. Because a number of variables have been
reported to impact on in vivo assembly, tailoring experimental
conditions can enhance experimental success.
Primer design
Unique primer design allows a variety of plasmid modi-
fications to be performed (Figs. 1 and 2). Insertion of small
sequences, deletions, or point mutagenesis all involve full plas-
mid amplification using primers binding astride the desired
modification site, with homologous sequences encoded at their
5 ends (Fig. 1A). Small insertions can be introduced by inclu-
sion in both forward and reverse primers to form the homo-
logous regions, whereas deletions simply exclude the undesired
plasmid regions from amplification. Subcloning is performed
by amplifying both vector and insert DNA with homologous
sequences encoded in primers for either vector or insert (Fig.
1B). A major advantage of this primer design approach is its
modularity, where primers for individual modifications can be
used in a combinatorial manner, allowing simultaneous and
complex plasmid modification (Fig. 2).
Homology design
The properties of homologous sequences have been opti-
mized to yield maximum efficiency. The length of homologous
regions is proportional to the efficiency of assembly, with at
least 15 bp offering reliable cloning (22, 23, 32). Bearing this in
mind, it is not the length per se that improves cloning efficiency,
but the “strength of homology annealing” (Tm) (22) (Fig. 1C).
This is important to consider because regions of relatively low
GC content may require longer homology arms for successful
cloning. The primary limitation on longer homology is the cost
of additional base pairs on primer purchasing, and homologies
longer than 30 bp are likely to cause unnecessary cost increases.
When performing one or two recombination events, homo-
logous regions with lower annealing temperatures are sufficient
(Tm around 50 °C), but when performing three or more recom-
bination events, Tm of these overlaps can be increased (Tm 
60 – 65 °C) to aid assembly. However, up to five simultaneous
mutations have been performed with primers containing ho-
mologous regions with Tm of 48 –52 °C (22).
Optimizing PCR
Although fragment assembly is independent of the PCR
amplification method, successful PCR amplification is the pri-
mary prerequisite for successful cloning. In difficult cases, the
use of PCR additives, such as DMSO (3%) or betaine (1 M), and
other additives, such as 1,2-propanediol and ethylene glycol
(77, 78), can facilitate amplification. As discussed previously,
alternative cloning routes are available to circumvent PCR
amplification if required. General PCR-cycling parameters are
dependent on the required amplification. Using high-fidelity
DNA polymerases such as Phusion or Q5 will minimize PCR-
introduced errors, in particular during vector amplification.
Similarly, minimizing cycle numbers to around 18 –20 yields
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sufficient DNA product while avoiding accumulation of muta-
tions (22, 32, 43).
Post-PCR DNA handling
Prior to transformation, original vector DNA must be re-
moved to limit false positive colony formation. Although
greatly reducing the level of template DNA is a possibility (34),
the required increase in PCR cycles for sufficient product for-
mation dramatically increases the likelihood of introducing
mutations during amplification. Using around 1 ng of template
plasmid and minimal PCR cycles (22, 24) is the best compro-
mise between yield and background noise. Post-PCR, incuba-
tion with DpnI is widely used to successfully remove the major-
ity of unwanted template DNA (22, 25, 43) and is the simplest
method for this purpose (Fig. 4). Post-PCR purification of DNA
fragments by gel extraction has been suggested (23, 32, 34), but
this laborious approach does not offer any advantages over
treatment with DpnI unless PCR amplification produces non-
specific products. Incubation of separately amplified PCR prod-
ucts together prior to transformation has been reported (32)
but is widely accepted to be unnecessary.
Transformation and bacterial strains
When transforming multiple fragments, the optimal insert/
vector ratio has been examined, but there is little consensus
about the ideal parameters. Whereas Jacobus and Gross (23)
show little influence of this factor, Kostylev et al. (25) show that
increasing insert/vector ratio can enhance colony formation,
up to a ceiling at 5:1. This ratio cannot be controlled when
performing single-tube cloning procedures (Fig. 4, Route 1), but
a higher stoichiometry of insert to vector is normally achieved
coincidentally, by the higher amplification efficiency of shorter
insert fragments than the lengthier vector backbone.
The vast majority of reports to date use chemically compe-
tent cells, as is widely standard for laboratory plasmid mainte-
nance. Because the RAIR pathway is ubiquitous in common
laboratory bacteria, the strain employed does not appear to be
critical, but note that some variations in efficiency have been
demonstrated (57). Successful cloning has been reported in the
commonly used DH5a (22, 23, 25), XL10-Gold (22), TOP10,
NEB5, NEB10, and BL21 (DE3) (32) strains, among others. A
direct comparison of bacteria strains with equivalent transfor-
mation efficiency has not been reported and could allow further
method optimization. Whereas strain choice is flexible, cell
competency is important. For procedures requiring single or
double recombination events, homemade cells of lower compe-
tency (106–107 cfu/g of DNA) are sufficient, but more com-
plex procedures with three or more recombination events
require highly competent cells (109 cfu/g) (22).
One caveat of RAIR cloning is the incorporation of small
fragments. A number of reports have highlighted poor cloning
efficiency when assembling small DNA fragments of less than
200 bp (25, 32). This may arise due to poor transformation
efficiency of small fragments or, possibly, their destruction by
complete single-stranded exonuclease activity. As an alterna-
tive, with synthesis of 110 bp oligonucleotides routinely possi-
ble at relatively low cost, modifications up to around 150 bp
apart can be introduced using a single pair of long primers.
Conclusion and future outlook
The simplification of molecular cloning procedures and
reduced cost and versatility of plasmid modification offered by
cloning using RecA-independent recombination (Fig. 5) give
this approach great potential to become the method of choice
for any laboratory in biomedical, biotechnological, and syn-
thetic biology research. The recently revived interest in the use
of RAIR for molecular cloning has also stimulated interest in
the mechanism of recombination. With a full mechanistic
understanding and identification of the proteins involved will
come the ability to develop RAIR-enhanced strains, allowing
Figure 5. Method overview. Through PCR amplification of DNA fragments, plasmid modifications of many varieties and homologous sequences to direct DNA
assembly are introduced. PCR template DNA can be destroyed by DpnI digestion. Circular propagative plasmid products are assembled by homologous
recombination in vivo.
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greater cloning complexity to be achieved. RAIR-enhanced
strains could avoid the plasmid instability issues of current
“recombination enhanced” bacteria, given the apparent lack of
RAIR action on circularized plasmids. Initial attempts have
been made toward enhanced-RAIR bacteria (57, 79, 80) but do
not appear yet to offer advantages great enough to warrant
widespread adoption. Of course, a major advantage of this tech-
nique is that “cloning-compatible” strains already exist in the
freezers of molecular biology laboratories across the world.
The approach holds promise not only for standard cloning
procedures, but also for high-throughput screening applica-
tions, where the versatility of homology-based approaches can
be employed in plasmid library construction, as proof-of-con-
cept studies have begun to suggest (22, 29, 32). With tumbling
costs for DNA synthesis and its suitability for use with the RAIR
pathway, future cloning approaches are likely to become sim-
pler and more versatile yet. It has been many years since cloning
using this elusive recombination pathway first stepped on stage,
but it seems that the time is now right for it to enjoy the
spotlight.
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